Trial Profile
Tamsulosin +/- solifenacin in men with benign prostatic hyperplasia and overactive bladder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2012
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Tamsulosin
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 23 Dec 2012 New trial record
- 19 Oct 2012 Results presented at the 42nd Annual Meeting of the International Continence Society.